164 related articles for article (PubMed ID: 19690126)
21. Aggrecanase versus matrix metalloproteinases in the catabolism of the interglobular domain of aggrecan in vitro.
Little CB; Flannery CR; Hughes CE; Mort JS; Roughley PJ; Dent C; Caterson B
Biochem J; 1999 Nov; 344 Pt 1(Pt 1):61-8. PubMed ID: 10548534
[TBL] [Abstract][Full Text] [Related]
22. Type II and VI collagen in nasal and articular cartilage and the effect of IL-1alpha on the distribution of these collagens.
Jansen ID; Hollander AP; Buttle DJ; Everts V
J Mol Histol; 2010 Feb; 41(1):9-17. PubMed ID: 20213143
[TBL] [Abstract][Full Text] [Related]
23. Esculetin inhibits cartilage resorption induced by interleukin 1alpha in combination with oncostatin M.
Elliott S; Rowan AD; Carrère S; Koshy P; Catterall JB; Cawston TE
Ann Rheum Dis; 2001 Feb; 60(2):158-65. PubMed ID: 11156550
[TBL] [Abstract][Full Text] [Related]
24. Human nasal cartilage responds to oncostatin M in combination with interleukin 1 or tumour necrosis factor alpha by the release of collagen fragments via collagenases.
Morgan TG; Rowan AD; Dickinson SC; Jones D; Hollander AP; Deehan D; Cawston TE
Ann Rheum Dis; 2006 Feb; 65(2):184-90. PubMed ID: 15975972
[TBL] [Abstract][Full Text] [Related]
25. Baekjeolyusin-tang and its active component berberine block the release of collagen and proteoglycan from IL-1β-stimulated rabbit cartilage and down-regulate matrix metalloproteinases in rabbit chondrocytes.
Moon PD; Jeong HS; Chun CS; Kim HM
Phytother Res; 2011 Jun; 25(6):844-50. PubMed ID: 21089182
[TBL] [Abstract][Full Text] [Related]
26. Synergistic effects of glycoprotein 130 binding cytokines in combination with interleukin-1 on cartilage collagen breakdown.
Rowan AD; Koshy PJ; Shingleton WD; Degnan BA; Heath JK; Vernallis AB; Spaull JR; Life PF; Hudson K; Cawston TE
Arthritis Rheum; 2001 Jul; 44(7):1620-32. PubMed ID: 11465713
[TBL] [Abstract][Full Text] [Related]
27. Interleukin-1 and oncostatin M in combination promote the release of collagen fragments from bovine nasal cartilage in culture.
Cawston TE; Ellis AJ; Humm G; Lean E; Ward D; Curry V
Biochem Biophys Res Commun; 1995 Oct; 215(1):377-85. PubMed ID: 7575616
[TBL] [Abstract][Full Text] [Related]
28. Interleukin-1alpha induction of tensile weakening associated with collagen degradation in bovine articular cartilage.
Temple MM; Xue Y; Chen MQ; Sah RL
Arthritis Rheum; 2006 Oct; 54(10):3267-76. PubMed ID: 17009261
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and mechanism of action of KHBJ-9B, a new herbal medicine, and its major compound triterpenoids in human cartilage culture and in a rabbit model of collagenase-induced osteoarthritis.
Huh JE; Baek YH; Ryu SR; Lee JD; Choi DY; Park DS
Int Immunopharmacol; 2009 Feb; 9(2):230-40. PubMed ID: 19100343
[TBL] [Abstract][Full Text] [Related]
30. Peptides of type II collagen can induce the cleavage of type II collagen and aggrecan in articular cartilage.
Yasuda T; Tchetina E; Ohsawa K; Roughley PJ; Wu W; Mousa A; Ionescu M; Pidoux I; Poole AR
Matrix Biol; 2006 Sep; 25(7):419-29. PubMed ID: 16919430
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of interleukin-1-induced proteoglycan degradation and nitric oxide production in bovine articular cartilage/chondrocyte cultures by the natural product, hymenialdisine.
Badger AM; Cook MN; Swift BA; Newman-Tarr TM; Gowen M; Lark M
J Pharmacol Exp Ther; 1999 Aug; 290(2):587-93. PubMed ID: 10411566
[TBL] [Abstract][Full Text] [Related]
32. Esculetin (dihydroxycoumarin) inhibits the production of matrix metalloproteinases in cartilage explants, and oral administration of its prodrug, CPA-926, suppresses cartilage destruction in rabbit experimental osteoarthritis.
Yamada H; Watanabe K; Saito T; Hayashi H; Niitani Y; Kikuchi T; Ito A; Fujikawa K; Lohmander LS
J Rheumatol; 1999 Mar; 26(3):654-62. PubMed ID: 10090178
[TBL] [Abstract][Full Text] [Related]
33. Lithium protects cartilage from cytokine-mediated degradation by reducing collagen-degrading MMP production via inhibition of the P38 mitogen-activated protein kinase pathway.
Hui W; Litherland GJ; Jefferson M; Barter MJ; Elias MS; Cawston TE; Rowan AD; Young DA
Rheumatology (Oxford); 2010 Nov; 49(11):2043-53. PubMed ID: 20634235
[TBL] [Abstract][Full Text] [Related]
34. Association of proteoglycan degradation with catabolic cytokine and stromelysin release from cartilage cultured with fibronectin fragments.
Homandberg GA; Hui F
Arch Biochem Biophys; 1996 Oct; 334(2):325-31. PubMed ID: 8900407
[TBL] [Abstract][Full Text] [Related]
35. Oncostatin M (OSM) stimulates resorption and inhibits synthesis of proteoglycan in porcine articular cartilage explants.
Hui W; Bell M; Carroll G
Cytokine; 1996 Jun; 8(6):495-500. PubMed ID: 8818547
[TBL] [Abstract][Full Text] [Related]
36. A new class of potent matrix metalloproteinase 13 inhibitors for potential treatment of osteoarthritis: Evidence of histologic and clinical efficacy without musculoskeletal toxicity in rat models.
Baragi VM; Becher G; Bendele AM; Biesinger R; Bluhm H; Boer J; Deng H; Dodd R; Essers M; Feuerstein T; Gallagher BM; Gege C; Hochgürtel M; Hofmann M; Jaworski A; Jin L; Kiely A; Korniski B; Kroth H; Nix D; Nolte B; Piecha D; Powers TS; Richter F; Schneider M; Steeneck C; Sucholeiki I; Taveras A; Timmermann A; Van Veldhuizen J; Weik J; Wu X; Xia B
Arthritis Rheum; 2009 Jul; 60(7):2008-18. PubMed ID: 19565489
[TBL] [Abstract][Full Text] [Related]
37. Synoviocytes are more sensitive than cartilage to the effects of minocycline and doxycycline on IL-1alpha and MMP-13-induced catabolic gene responses.
Fortier LA; Motta T; Greenwald RA; Divers TJ; Mayr KG
J Orthop Res; 2010 Apr; 28(4):522-8. PubMed ID: 19813262
[TBL] [Abstract][Full Text] [Related]
38. Effects of glucocorticoids and interleukin-1 beta on expression and activity of aggrecanases in equine chondrocytes.
Busschers E; Holt JP; Richardson DW
Am J Vet Res; 2010 Feb; 71(2):176-85. PubMed ID: 20113225
[TBL] [Abstract][Full Text] [Related]
39. Catabolism of Fibromodulin in Developmental Rudiment and Pathologic Articular Cartilage Demonstrates Novel Roles for MMP-13 and ADAMTS-4 in C-terminal Processing of SLRPs.
Shu CC; Flannery CR; Little CB; Melrose J
Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30700002
[TBL] [Abstract][Full Text] [Related]
40. Relative contribution of matrix metalloprotease and cysteine protease activities to cytokine-stimulated articular cartilage degradation.
Sondergaard BC; Henriksen K; Wulf H; Oestergaard S; Schurigt U; Bräuer R; Danielsen I; Christiansen C; Qvist P; Karsdal MA
Osteoarthritis Cartilage; 2006 Aug; 14(8):738-48. PubMed ID: 16563811
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
